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ABSTRACT
The utility of a rapid antigen test for diagnosing
cases of persistent giardiasis, as deﬁned by
detection of cysts by conventional microscopy
following standard formalin–ether concentration
or the positive rapid antigen test, was investi-
gated following a large, waterborne outbreak of
giardiasis. The sensitivity and speciﬁcity of the
rapid test as compared with microscopy were
60.7% and 96.7%, respectively, in this patient
group. The low sensitivity contrasts with previous
reports, and may be partly explained by low cyst
numbers.
Keywords diagnosis, Giardia duodenalis, Giardiasis,
persistent infection, rapid test
Original Submission: 21 December 2007; Revised
Submission: 7 May 2008; Accepted: 28 May 2008
Edited by P. Brouqui
Clin Microbiol Infect 2008; 14: 1069–1071
10.1111/j.1469-0691.2008.02078.x
During the autumn of 2004, an extensive outbreak
of waterborne giardiasis occurred in Bergen, Nor-
way [1,2]. Nearly 1300 patients were diagnosed
with giardiasis at the Laboratory for Parasitic
Diseases at Haukeland University Hospital, Ber-
gen, Norway. During the initial recognition of the
outbreak, diagnosis of Giardia duodenalis infection
relied on conventional microscopy following stan-
dard formalin–ether concentration. This procedure
is time-consuming and requires experienced per-
sonnel. At the outbreak peak, the number of
samples submitted for examination for Giardia
infection was over 30 times higher than normal,
and it was essential to reduce the time expended
per sample. Therefore, use of the ImmunoCard
STAT!Cryptosporidium ⁄Giardia rapid assay (Merid-
ian Bioscience, Inc., Cincinnati, OH, USA) faecal
antigen test, which has been reported to have high
sensitivity (81–93.5%) and speciﬁcity (>99%) [3,4],
was introduced at the diagnostic laboratory. Prior
to implementation of this method, 31 samples
positive for Giardia according to conventional
microscopy were analysed by the antigen test,
and 29 (94%) were positive. As this was consistent
with published sensitivity data, it was considered
to be sufﬁcient to implement this test as a diagnos-
tic method in the laboratory, although speciﬁcity
tests were not being performed.
A signiﬁcant proportion of patients with clin-
ical giardiasis do not respond satisfactorily to
treatment [5–13]. It is important to differentiate
between patients with persistent infections and
those with persistent symptoms but who are no
longer infected. The former serve as a source of
continued transmission. All patient samples were
also examined for other parasites by microscopy
and were cultured for enteropathogenic bacteria.
In an extensive outbreak situation, a relatively
large number of patients are likely to have
refractory infections, which, if undetected, have
the potential to signiﬁcantly increase the number
of secondary infections. No data concerning the
use of antigen tests for the diagnosis of Giardia in
this group were found, but antigen tests have
been suggested as being particularly helpful in
assessing the rate of cure [9].
The aim of this study was to examine the
sensitivity and speciﬁcity of the rapid antigen test
for diagnosing patients with persistent symptoms
and possible infection following treatment.
Following the outbreak described above, 124
patients were referred to the hospital outpatient
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clinic for further testing. This is approximately
10% of the total number of patients diagnosed,
and is not surprising in an outbreak of this size
[5,8,10,12–14]. All patients had been treated with
metronidazole, usually two to three cycles, and
most had reported temporary relief of symptoms
immediately following treatment. The period
between initial diagnosis and examination in the
outpatient clinic was >3 months for over 75% of
the patients. In total, 742 faecal samples were
analysed by both conventional microscopy, fol-
lowing standard formalin–ether concentration,
and the antigen test. Weekly samples were
obtained from those patients who were excreting
Giardia cysts, or had a positive antigen test at their
ﬁrst visit to the outpatient clinic. Additionally,
two or three more samples were submitted at the
follow-up consultation approximately 6 weeks
later.
Samples that tested positive according to
microscopy were considered to be true positives.
Among the 742 samples examined by both
conventional microscopy and the rapid antigen
test (Table 1), 609 tested negative according to
both methods, and 68 tested positive according
to both. Forty-four samples tested positive
according to microscopy, but negative according
to the antigen test. Twenty-one tested negative
according to microscopy, but positive according
to the antigen test. The sensitivity and speciﬁcity
of the antigen test in this patient group can
therefore be calculated to be 60.7% and 96.7%,
respectively, if using microscopy as the reference
standard. The 21 samples that tested positive
according to the antigen test, but tested negative
according to microscopy, may be true false
positives; alternatively, they may represent
patients who still have detectable soluble antigen
in their stool, despite having cleared the para-
sites, or they may be false negatives according to
microscopy.
Some of the microscopy-positive samples
(n = 51, 30 of which had tested positive according
to the antigen test and 21 of which had tested
negative according to the antigen test) were also
examined by immunoﬂuorescence (GC-Combo;
Waterborne Inc., New Orleans, LA, USA) follow-
ing salt ﬂotation. Although PCR is highly sensi-
tive in some situations, various studies suggest
that diagnostic tools such as immunoﬂuorescence
assay are equally, or more, sensitive [15,16].
The intensity of infection for each sample was
categorized by cyst number at 200· magniﬁcation
as follows: +, <10 cysts per ﬁeld of view; ++, >10
to <50 cysts per ﬁeld of view; and +++, >50 cysts
per ﬁeld of view. Among the 30 samples that had
tested positive according to the rapid antigen test,
ten were categorized as +++, and ﬁve as ++.
Among the 21 samples that had tested negative
according to the antigen test, two were categor-
ized as either ++ or +++. A signiﬁcantly higher
proportion of samples that tested negative accord-
ing to the antigen test had low cyst numbers (+) as
compared to samples that tested positive accord-
ing to the antigen test (Fisher’s exact test,
p 0.0028; Table 2).
Among the 124 patients, 57 were found to be
still infected, according to microscopy, the antigen
test or both. Twelve of these patients tested
positive only according to microscopy, and hence
would not have been diagnosed as having per-
sistent infections if only examined by the antigen
test.
Antigen tests have been shown to be useful for
diagnosis of giardiasis, and are of particular value
in an outbreak setting, where the workload is
likely to exceed the laboratory capacity. However,
these results indicate that, for diagnosis of
patients with refractory or persistent giardiasis
following treatment, this antigen test should be
used with caution, as its sensitivity is compro-
mised. These results suggest that part of the
explanation is that parasite load is diminished in
these patients, presumably resulting in less anti-
gen production, which has also been suggested in
Table 1. Results of Giardia diagnosis in faecal samples by
conventional microscopy and rapid antigen test
Rapid test
positive
Rapid test
negative Total
Microscopy positive 68 44 112
Microscopy negative 21 609 630
Total 89 653 742
Table 2. Antigen test results by cyst numbers (quantiﬁed
by ﬂuorescence microscopy) in samples from patients with
persistent giardiasis
Rapid
test
positive
Rapid
test
negative Total
Percentage
positive
of total (%)
+ (<10 cysts per
ﬁeld of view)
15 19 34 44
++ and above
(>10 cysts per ﬁeld of view)
15 2 17 88
Total 30 21 51 59
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earlier studies [3,4]. On the basis of these ﬁndings,
we do not recommend using the faecal antigen
test for follow-up of patients with persistent
symptoms after being treated for giardiasis.
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